ArticleBiomacromolecules2020

Nanoparticles Presenting Potent TLR7/8 Agonists Enhance Anti-PD-L1 Immunotherapy in Cancer Treatment.

Anton A A Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.